- Home
- ADRX vs VERA Comparison
ADRX vs VERA Comparison
Compare ADRX & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$17.49
HOLD
Current Price
$28.11
Company Overview
Basic Information| Metric | ADRX | VERA |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2026 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ADRX | VERA |
|---|---|---|
| Price | $17.49 | $28.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | $35.00 | ★ $74.20 |
| AVG Volume (30 Days) | 487.3K | ★ 1.6M |
| Earning Date | 11-15-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $863.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.61 | $23.05 |
| 52 Week High | $19.57 | $56.05 |
Technical Indicators
Market Signals| Indicator | ADRX | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 42.13 |
| Support Level | $16.85 | $26.38 |
| Resistance Level | $18.99 | $36.95 |
| Average True Range (ATR) | 1.24 | 1.66 |
| MACD | -0.04 | 0.16 |
| Stochastic Oscillator | 26.73 | 35.68 |
Price Performance
Historical Comparison ADRX
VERA
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.